Venture Life Repurchases Shares Under Ongoing Buyback Programme

Venture Life ( (GB:VLG) ) has issued an announcement.

Venture Life Group has continued its share buyback programme, repurchasing 55,676 ordinary shares at a volume-weighted average price of 68.70 pence per share, with the shares to be held in treasury. Following this transaction, the company has 128,860,145 ordinary shares in issue, of which 6,033,451 are held in treasury, leaving 122,826,694 voting rights, a figure investors can use to assess disclosure thresholds under FCA transparency rules.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is an international consumer self-care company focused on proactive healthy longevity within the global consumer healthcare sector. Headquartered in the UK, it markets products such as Balance Activ for women’s intimate healthcare, Earol for ENT care, Lift and Glucogel for energy and glucose management, and Health & Her for hormonal lifecycle support through pharmacies, health and beauty retailers, grocery chains, and e-commerce channels worldwide.

Average Trading Volume: 325,536

Technical Sentiment Signal: Buy

Current Market Cap: £84.48M

Learn more about VLG stock on TipRanks’ Stock Analysis page.